Tacalyx

OverviewSuggest Edit

Tacalyx is a biotech company that focuses on the discovery and development of novel anti-TACA (tumor-associated carbohydrate antigens) cancer therapies. The company develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.

TypePrivate
Founded2019
HQBerlin, DE
Websitetacalyx.com

Locations

Tacalyx is headquartered in
Berlin, Germany

Location Map

Latest Updates

Cybersecurity ratingAMore

Tacalyx Office Locations

Tacalyx has an office in Berlin
Berlin, DE (HQ)
Müllerstraße 178
Show all (1)

Tacalyx Financials and Metrics

Summary Metrics

Founding Date

2019

Tacalyx total Funding

$7.7 m

Tacalyx latest funding size

$7.66 m

Time since last funding

a year ago

Tacalyx investors

Tacalyx's latest funding round in September 2019 was reported to be $7.7 m. In total, Tacalyx has raised $7.7 m
Show all financial metrics

Tacalyx Cybersecurity Score

Cybersecurity ratingPremium dataset

A

96/100

SecurityScorecard logo

Tacalyx Online and Social Media Presence

Embed Graph

Tacalyx Frequently Asked Questions

  • When was Tacalyx founded?

    Tacalyx was founded in 2019.

  • Who are Tacalyx competitors?

    Competitors of Tacalyx include Quench Bio, AIVITA Biomedical and Veravas.

  • Where is Tacalyx headquarters?

    Tacalyx headquarters is located at Müllerstraße 178, Berlin.

  • Where are Tacalyx offices?

    Tacalyx has an office in Berlin.

  • How many offices does Tacalyx have?

    Tacalyx has 1 office.